Featured Article
Precision Oncology Today
Magazine
5 Key Startups Bringing Digital Pathology Into Focus
Digital pathology is driving precision medicine by turbocharging the analysis of tissue slides. Here are the five top startups turning microscopy into a data...
How Is Artificial Intelligence Changing the Clinical Trials Landscape?
There is no doubt that artificial intelligence (AI) is currently en vogue. Many AI and machine-learning applications are already being deployed in drug discovery and development. Not only can AI process, analyze, and interpret huge datasets, it can also be used for structural drug design and toxicity and efficacy predictions.
Trending on Inside Precision Medicine
AMP Expo Chatter: Can AI Algorithms Be LDTs?
Conversations at the conference brought to light a topic of growing importance to the molecular pathology community and the diagnostics community at large—the use of artificial intelligence (AI) as laboratory-developed tests (LDTs).
Spatial Transcriptomics Offer New Insights into Alzheimer’s Disease
A transcriptomics analysis of Alzheimer’s disease—looking at the spatial differences in gene expression found across the brains of patients with early-stage and late-stage Alzheimer’s, as well as Alzheimer’s disease in Down syndrome—uncovered new clues about disease processes that are intimately tied to specific cell types and brain regions.
New Atlas of the Plasma Proteome Provides Important Insights into Health and Disease
A new atlas of the human plasma proteome can enable precision medicine through new insights into health and disease.